These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19506586)

  • 21. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
    Götestam Skorpen C; Hoeltzenbein M; Tincani A; Fischer-Betz R; Elefant E; Chambers C; da Silva J; Nelson-Piercy C; Cetin I; Costedoat-Chalumeau N; Dolhain R; Förger F; Khamashta M; Ruiz-Irastorza G; Zink A; Vencovsky J; Cutolo M; Caeyers N; Zumbühl C; Østensen M
    Ann Rheum Dis; 2016 May; 75(5):795-810. PubMed ID: 26888948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.
    Alten R; Burkhardt H; Feist E; Krüger K; Rech J; Rubbert-Roth A; Voll RE; Elbez Y; Rauch C
    Arthritis Res Ther; 2018 Jan; 20(1):1. PubMed ID: 29329602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid arthritis.
    Emery P; Suarez-Almazor M
    Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 25. Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis.
    Henes JC; Schedel J; Kanz L; Koetter I
    Rheumatol Int; 2010 Mar; 30(5):709-12. PubMed ID: 20012622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease modification in rheumatoid arthritis with leflunomide.
    Emery P
    Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2018 Jul; 60(1552):123-128. PubMed ID: 30044766
    [No Abstract]   [Full Text] [Related]  

  • 29. Leflunomide: a review of its use in active rheumatoid arthritis.
    Prakash A; Jarvis B
    Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.
    Woodworth TG; den Broeder AA
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):543-9. PubMed ID: 26697765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab.
    Luong BT; Chong BS; Lowder DM
    Ann Pharmacother; 2000 Jun; 34(6):743-60. PubMed ID: 10860137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety of rheumatic disease drugs at childbearing age].
    Zrour-Hassen S; Jguirim M; Aouam K; Korbaa W; Younes M; Bejia I; Touzi M; Bergaoui N
    Therapie; 2010; 65(5):465-73. PubMed ID: 21144482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rational therapeutic approach in rheumatoid arthritis].
    Tłustochowicz W
    Ann Acad Med Stetin; 2006; 52 Suppl 2():5-10. PubMed ID: 17471832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
    Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
    BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
    Kremer JM
    Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
    Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
    Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy].
    Matuszewska A; Misterska-Skóra M; Wiland P
    Ann Acad Med Stetin; 2010; 56 Suppl 1():45-7. PubMed ID: 21365940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leflunomide in the treatment of rheumatoid arthritis.
    Li EK; Tam LS; Tomlinson B
    Clin Ther; 2004 Apr; 26(4):447-59. PubMed ID: 15189743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional therapy of psoriatic arthritis: evidence-based review.
    McHugh NJ; Soriano ER
    Reumatismo; 2007; 59 Suppl 1():81-4. PubMed ID: 17828352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.
    Ojeda-Uribe M; Afif N; Dahan E; Sparsa L; Haby C; Sibilia J; Ternant D; Ardizzone M
    Clin Rheumatol; 2013 May; 32(5):695-700. PubMed ID: 23292481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.